ArticleInternational journal of oncology2019

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.

Runjia Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.